| Year |
Citation |
Score |
| 2013 |
Couvineau A, Tan YV, Ceraudo E, Laburthe M. Strategies for studying the ligand binding site of GPCRs: photoaffinity labeling of the VPAC1 receptor, a prototype of class B GPCRs. Methods in Enzymology. 520: 219-37. PMID 23332702 DOI: 10.1016/B978-0-12-391861-1.00010-1 |
0.4 |
|
| 2012 |
Couvineau A, Ceraudo E, Tan YV, Nicole P, Laburthe M. The VPAC1 receptor: structure and function of a class B GPCR prototype. Frontiers in Endocrinology. 3: 139-139. PMID 23162538 DOI: 10.3389/Fendo.2012.00139 |
0.402 |
|
| 2012 |
Ceraudo E, Hierso R, Tan YV, Murail S, Rouyer-Fessard C, Nicole P, Robert JC, Jamin N, Neumann JM, Robberecht P, Laburthe M, Couvineau A. Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2060-71. PMID 22291440 DOI: 10.1096/Fj.11-196444 |
0.443 |
|
| 2012 |
Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. British Journal of Pharmacology. 166: 4-17. PMID 22289055 DOI: 10.1111/J.1476-5381.2012.01871.X |
0.472 |
|
| 2012 |
Couvineau A, Laburthe M. VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins. British Journal of Pharmacology. 166: 42-50. PMID 21951273 DOI: 10.1111/j.1476-5381.2011.01676.x |
0.323 |
|
| 2012 |
Couvineau A, Laburthe M. The family B1 GPCR: structural aspects and interaction with accessory proteins. Current Drug Targets. 13: 103-15. PMID 21777182 DOI: 10.2174/138945012798868434 |
0.438 |
|
| 2012 |
Laburthe M, Voisin T. The orexin receptor OX(1)R in colon cancer: a promising therapeutic target and a new paradigm in G protein-coupled receptor signalling through ITIMs. British Journal of Pharmacology. 165: 1678-87. PMID 21627633 DOI: 10.1111/J.1476-5381.2011.01510.X |
0.388 |
|
| 2012 |
Voisin T, Firar AE, couvineau a, laburthe m. Abstract 1215: Orexin and their 7-membrane spanning receptors OX1R: a new colon cancer therapeutic target Cancer Research. 72: 1215-1215. DOI: 10.1158/1538-7445.Am2012-1215 |
0.378 |
|
| 2011 |
Passemard S, El Ghouzzi V, Nasser H, Verney C, Vodjdani G, Lacaud A, Lebon S, Laburthe M, Robberecht P, Nardelli J, Mani S, Verloes A, Gressens P, Lelièvre V. VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling. The Journal of Clinical Investigation. 121: 3071-87. PMID 21737879 DOI: 10.1172/Jci43824 |
0.356 |
|
| 2011 |
Voisin T, El Firar A, Fasseu M, Rouyer-Fessard C, Descatoire V, Walker F, Paradis V, Bedossa P, Henin D, Lehy T, Laburthe M. Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis. Cancer Research. 71: 3341-51. PMID 21415167 DOI: 10.1158/0008-5472.Can-10-3473 |
0.333 |
|
| 2011 |
Zweibaum A, Laburthe M, Grasset E, Louvard D. Use of Cultured Cell Lines in Studies of Intestinal Cell Differentiation and Function Comprehensive Physiology. 223-255. DOI: 10.1002/Cphy.Cp060407 |
0.354 |
|
| 2011 |
Laburthe M, Amiranoff B. Peptide Receptors in Intestinal Epithelium Comprehensive Physiology. 215-243. DOI: 10.1002/Cphy.Cp060211 |
0.484 |
|
| 2010 |
Couvineau A, Ceraudo E, Tan Y-, Laburthe M. VPAC1 receptor binding site: contribution of photoaffinity labeling approach. Neuropeptides. 44: 127-132. PMID 20031208 DOI: 10.1016/J.Npep.2009.11.008 |
0.449 |
|
| 2010 |
Laburthe M, Voisin T, Firar AE. Orexins/hypocretins and orexin receptors in apoptosis: a mini-review. Acta Physiologica. 198: 393-402. PMID 19719798 DOI: 10.1111/J.1748-1716.2009.02035.X |
0.416 |
|
| 2009 |
El Firar A, Voisin T, Rouyer-Fessard C, Ostuni MA, Couvineau A, Laburthe M. Discovery of a functional immunoreceptor tyrosine-based switch motif in a 7-transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 4069-80. PMID 19661287 DOI: 10.1096/Fj.09-131367 |
0.413 |
|
| 2009 |
Bourgault S, Vaudry D, Ségalas-Milazzo I, Guilhaudis L, Couvineau A, Laburthe M, Vaudry H, Fournier A. Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor. Journal of Medicinal Chemistry. 52: 3308-16. PMID 19413310 DOI: 10.1021/Jm900291J |
0.436 |
|
| 2009 |
Gratio V, Walker F, Lehy T, Laburthe M, Darmoul D. Aberrant expression of proteinase-activated receptor 4 promotes colon cancer cell proliferation through a persistent signaling that involves Src and ErbB-2 kinase. International Journal of Cancer. 124: 1517-25. PMID 19058300 DOI: 10.1002/Ijc.24070 |
0.417 |
|
| 2009 |
Laburthe M. Peptide YY and neuropeptide Y in the gut: availability, biological actions, and receptors. Trends in Endocrinology and Metabolism: Tem. 1: 168-74. PMID 18411113 DOI: 10.1016/1043-2760(90)90031-W |
0.48 |
|
| 2008 |
Aubert N, Vaudry D, Falluel-Morel A, Desfeux A, Fisch C, Ancian P, de Jouffrey S, Le Bigot JF, Couvineau A, Laburthe M, Fournier A, Laudenbach V, Vaudry H, Gonzalez BJ. PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: involvement of the mitochondrial apoptotic pathway. Neurobiology of Disease. 32: 66-80. PMID 18652895 DOI: 10.1016/J.Nbd.2008.06.014 |
0.34 |
|
| 2008 |
Ceraudo E, Tan YV, Nicole P, Couvineau A, Laburthe M. The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptor. Journal of Molecular Neuroscience : Mn. 36: 245-8. PMID 18597186 DOI: 10.1007/S12031-008-9073-7 |
0.433 |
|
| 2008 |
Couvineau A, Robert JC, Ramdani T, Lacapère JJ, Rouyer-Fessard C, Laburthe M. Production and purification of large quantities of the functional N-terminal ectodomain of human VPAC1 receptor. Journal of Molecular Neuroscience : Mn. 36: 249-53. PMID 18592417 DOI: 10.1007/S12031-008-9072-8 |
0.419 |
|
| 2008 |
Neumann JM, Couvineau A, Murail S, Lacapère JJ, Jamin N, Laburthe M. Class-B GPCR activation: is ligand helix-capping the key? Trends in Biochemical Sciences. 33: 314-9. PMID 18555686 DOI: 10.1016/J.Tibs.2008.05.001 |
0.406 |
|
| 2008 |
Bourgault S, Vaudry D, Guilhaudis L, Raoult E, Couvineau A, Laburthe M, Ségalas-Milazzo I, Vaudry H, Fournier A. Biological and structural analysis of truncated analogs of PACAP27. Journal of Molecular Neuroscience : Mn. 36: 260-9. PMID 18473187 DOI: 10.1007/S12031-008-9081-7 |
0.408 |
|
| 2008 |
Bourgault S, Vaudry D, Botia B, Couvineau A, Laburthe M, Vaudry H, Fournier A. Novel stable PACAP analogs with potent activity towards the PAC1 receptor. Peptides. 29: 919-32. PMID 18353507 DOI: 10.1016/J.Peptides.2008.01.022 |
0.439 |
|
| 2008 |
Voisin T, El Firar A, Rouyer-Fessard C, Gratio V, Laburthe M. A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 1993-2002. PMID 18198212 DOI: 10.1096/Fj.07-098723 |
0.402 |
|
| 2008 |
Ceraudo E, Murail S, Tan YV, Lacapère JJ, Neumann JM, Couvineau A, Laburthe M. The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics. Molecular Endocrinology (Baltimore, Md.). 22: 147-55. PMID 17885205 DOI: 10.1210/Me.2007-0361 |
0.432 |
|
| 2007 |
Jarry A, Dorso L, Gratio V, Forgue-Lafitte ME, Laburthe M, Laboisse CL, Darmoul D. PAR-2 activation increases human intestinal mucin secretion through EGFR transactivation. Biochemical and Biophysical Research Communications. 364: 689-94. PMID 18028876 DOI: 10.1016/J.Bbrc.2007.10.073 |
0.433 |
|
| 2007 |
Laburthe M, Couvineau A, Tan V. Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology. Peptides. 28: 1631-9. PMID 17574305 DOI: 10.1016/J.Peptides.2007.04.026 |
0.433 |
|
| 2006 |
Tan YV, Couvineau A, Lacapere JJ, Laburthe M. Characterization of the new photoaffinity probe (Bz2-K24)-VIP. Annals of the New York Academy of Sciences. 1070: 575-80. PMID 16888228 DOI: 10.1196/Annals.1317.084 |
0.4 |
|
| 2006 |
Debaigt C, Meunier AC, Goursaud S, Montoni A, Pineau N, Couvineau A, Laburthe M, Muller JM, Janet T. Expression and GTP sensitivity of peptide histidine isoleucine high-affinity-binding sites in rat Annals of the New York Academy of Sciences. 1070: 215-219. PMID 16888169 DOI: 10.1196/Annals.1317.017 |
0.434 |
|
| 2006 |
Couvineau A, Tan YV, Ceraudo E, Lacapère JJ, Murail S, Neumann JM, Laburthe M. The human VPAC1 receptor: identification of the N-terminal ectodomain as a major VIP-binding site by photoaffinity labeling and 3D modeling. Annals of the New York Academy of Sciences. 1070: 205-9. PMID 16888167 DOI: 10.1196/Annals.1317.015 |
0.415 |
|
| 2006 |
Voisin T, Firar AE, Avondo V, Laburthe M. Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor. Endocrinology. 147: 4977-84. PMID 16857748 DOI: 10.1210/En.2006-0201 |
0.703 |
|
| 2006 |
Tan YV, Couvineau A, Murail S, Ceraudo E, Neumann JM, Lacapère JJ, Laburthe M. Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling. The Journal of Biological Chemistry. 281: 12792-8. PMID 16520374 DOI: 10.1074/Jbc.M513305200 |
0.463 |
|
| 2005 |
AMIRANOFF B, LORINET A, LAGNY-POURMIR I, LABURTHE M. Mechanism of galanin-inhibited insulin release European Journal of Biochemistry. 177: 147-152. DOI: 10.1111/J.1432-1033.1988.Tb14355.X-I2 |
0.369 |
|
| 2005 |
Vaudry H, Laburthe M. 7th International Symposium on VIP, PACAP and Related Peptides Rouen, France September, 11–14, 2005 Regulatory Peptides. 130: 133-188. DOI: 10.1016/J.Regpep.2005.06.011 |
0.327 |
|
| 2004 |
Couvineau A, Rouyer-Fessard C, Laburthe M. Presence of a N-terminal signal peptide in class II G protein-coupled receptors: crucial role for expression of the human VPAC1 receptor. Regulatory Peptides. 123: 181-5. PMID 15518910 DOI: 10.1016/J.Regpep.2004.06.025 |
0.489 |
|
| 2004 |
Rouet-Benzineb P, Rouyer-Fessard C, Jarry A, Avondo V, Pouzet C, Yanagisawa M, Laboisse C, Laburthe M, Voisin T. Orexins acting at native OX(1) receptor in colon cancer and neuroblastoma cells or at recombinant OX(1) receptor suppress cell growth by inducing apoptosis. The Journal of Biological Chemistry. 279: 45875-86. PMID 15310763 DOI: 10.1074/Jbc.M404136200 |
0.43 |
|
| 2004 |
Tan YV, Couvineau A, Laburthe M. Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the N-terminal ectodomain of human VPAC1 receptor by photoaffinity labeling with [Bpa6]-VIP. The Journal of Biological Chemistry. 279: 38889-94. PMID 15247290 DOI: 10.1074/Jbc.M404460200 |
0.489 |
|
| 2004 |
Darmoul D, Gratio V, Devaud H, Laburthe M. Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. The Journal of Biological Chemistry. 279: 20927-34. PMID 15010475 DOI: 10.1074/Jbc.M401430200 |
0.419 |
|
| 2003 |
Marie JC, Rouyer-Fessard C, Couvineau A, Nicole P, Devaud H, El Benna J, Laburthe M. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor. Molecular Pharmacology. 64: 1565-74. PMID 14645688 DOI: 10.1124/Mol.64.6.1565 |
0.449 |
|
| 2003 |
Tan YV, Couvineau A, Van Rampelbergh J, Laburthe M. Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptor. The Journal of Biological Chemistry. 278: 36531-6. PMID 12807902 DOI: 10.1074/Jbc.M304770200 |
0.514 |
|
| 2003 |
Darmoul D, Gratio V, Devaud H, Lehy T, Laburthe M. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. The American Journal of Pathology. 162: 1503-13. PMID 12707033 DOI: 10.1016/S0002-9440(10)64283-6 |
0.423 |
|
| 2003 |
Couvineau A, Lacapere JJ, Tan YV, Rouyer-Fessard C, Nicole P, Laburthe M. Identification of cytoplasmic domains of hVPAC1 receptor required for activation of adenylyl cyclase. Crucial role of two charged amino acids strictly conserved in class II G protein-coupled receptors. The Journal of Biological Chemistry. 278: 24759-66. PMID 12690118 DOI: 10.1074/Jbc.M301916200 |
0.427 |
|
| 2003 |
Voisin T, Rouet-Benzineb P, Reuter N, Laburthe M. Orexins and their receptors: structural aspects and role in peripheral tissues. Cellular and Molecular Life Sciences. 60: 72-87. PMID 12613659 DOI: 10.1007/S000180300005 |
0.425 |
|
| 2003 |
Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvineau A, Kuwasako K, Tilakaratne N, Sexton PM. Novel receptor partners and function of receptor activity-modifying proteins. The Journal of Biological Chemistry. 278: 3293-7. PMID 12446722 DOI: 10.1074/jbc.C200629200 |
0.361 |
|
| 2003 |
Laburthe M, Couvineau A. Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP. Regulatory Peptides. 108: 165-73. PMID 12220741 DOI: 10.1016/S0167-0115(02)00099-X |
0.446 |
|
| 2003 |
Marie J, Rouyer-Fessard C, Couvineau A, Nicole P, Laburthe M. Desensitization and internalization of human type 1 vasoactive intestinal peptide receptor(VPAC1)expressed in CHO cells. A mutagenesis study Gastroenterology. 124: A466. DOI: 10.1016/S0016-5085(03)82358-2 |
0.502 |
|
| 2002 |
Du K, Couvineau A, Rouyer-Fessard C, Nicole P, Laburthe M. Human VPAC1 receptor selectivity filter. Identification of a critical domain for restricting secretin binding. The Journal of Biological Chemistry. 277: 37016-22. PMID 12133828 DOI: 10.1074/Jbc.M203049200 |
0.496 |
|
| 2002 |
Ducroc R, Bontemps C, Marazova K, Devaud H, Darmoul D, Laburthe M. Trypsin is produced by and activates protease-activated receptor-2 in human cancer colon cells: evidence for new autocrine loop. Life Sciences. 70: 1359-67. PMID 11883712 DOI: 10.1016/S0024-3205(01)01519-3 |
0.407 |
|
| 2002 |
Laburthe M, Couvineau A, Marie J. VPAC Receptors for VIP and PACAP Receptors and Channels. 8: 137-153. DOI: 10.3109/10606820213680 |
0.437 |
|
| 2001 |
Buyse M, Berlioz F, Guilmeau S, Tsocas A, Voisin T, Péranzi G, Merlin D, Laburthe M, Lewin MJ, Rozé C, Bado A. PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. The Journal of Clinical Investigation. 108: 1483-94. PMID 11714740 DOI: 10.1172/Jci13219 |
0.403 |
|
| 2001 |
Darmoul D, Marie JC, Devaud H, Gratio V, Laburthe M. Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. British Journal of Cancer. 85: 772-9. PMID 11531266 DOI: 10.1054/Bjoc.2001.1976 |
0.425 |
|
| 2001 |
Goumain M, Voisin T, Lorinet AM, Ducroc R, Tsocas A, Rozé C, Rouet-Benzineb P, Herzog H, Balasubramaniam A, Laburthe M. The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning. Molecular Pharmacology. 60: 124-34. PMID 11408607 DOI: 10.1124/Mol.60.1.124 |
0.562 |
|
| 2001 |
Nicole P, Rouyer-Fessard C, Couvineau A, Drouot C, Fulcrand P, Martinez J, Laburthe M. Alanine scanning of VIP. Structure-function relationship for binding to human recombinant VPAC1 receptor. Annals of the New York Academy of Sciences. 921: 352-6. PMID 11193851 DOI: 10.1111/J.1749-6632.2000.Tb06992.X |
0.405 |
|
| 2000 |
Lins L, Couvineau A, Rouyer-Fessard C, Nicole P, Maoret JJ, Benhamed M, Brasseur R, Thomas A, Laburthe M. The human VPAC1 receptor: three-dimensional model and mutagenesis of the N-terminal domain. The Journal of Biological Chemistry. 276: 10153-60. PMID 11124960 DOI: 10.1074/Jbc.M009730200 |
0.447 |
|
| 2000 |
Nicole P, Maoret JJ, Couvineau A, Momany FA, Laburthe M. Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding. Biochemical and Biophysical Research Communications. 276: 654-9. PMID 11027527 DOI: 10.1006/Bbrc.2000.3375 |
0.448 |
|
| 2000 |
Balasubramaniam A, Tao Z, Zhai W, Stein M, Sheriff S, Chance WT, Fischer JE, Eden PE, Taylor JE, Liu CD, McFadden DW, Voisin T, Roze C, Laburthe M. Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine. Journal of Medicinal Chemistry. 43: 3420-7. PMID 10978189 DOI: 10.1021/Jm000052Z |
0.48 |
|
| 2000 |
Goumain M, Voisin T, Laburthe M. Y receptors characterized by RT-PCR. Distribution in rat intestine. Methods in Molecular Biology (Clifton, N.J.). 153: 209-17. PMID 10957995 DOI: 10.1385/1-59259-042-X:209 |
0.41 |
|
| 2000 |
Voisin T, Lorinet AM, Goumain M, Laburthe M. A G alpha i RNA-antisense expression strategy to investigate coupling of peptide YY/neuropeptide Y receptor to G alpha i. Methods in Molecular Biology (Clifton, N.J.). 153: 115-28. PMID 10957989 DOI: 10.1385/1-59259-042-X:115 |
0.344 |
|
| 2000 |
Nicole P, Lins L, Rouyer-Fessard C, Drouot C, Fulcrand P, Thomas A, Couvineau A, Martinez J, Brasseur R, Laburthe M. Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide. The Journal of Biological Chemistry. 275: 24003-12. PMID 10801840 DOI: 10.1074/Jbc.M002325200 |
0.518 |
|
| 2000 |
COUVINEAU A, MAORET J, ROUYER-FESSARD C, CARRERO I, LABURTHE M. The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20 Biochemical Journal. 347: 623. DOI: 10.1042/Bj3470623 |
0.449 |
|
| 2000 |
Darmoul D, Gratio V, Marie J, Devaud H, Laburthe MC. Expression of functional protease-activated receptors (PARs) for thrombin and trypsin in human colon cancer cells: Role in cell proliferation Gastroenterology. 118: A688. DOI: 10.1016/S0016-5085(00)84884-2 |
0.32 |
|
| 1999 |
Maoret JJ, Anini Y, Rouyer-Fessard C, Gully D, Laburthe M. Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice. International Journal of Cancer. Journal International Du Cancer. 80: 448-54. PMID 9935189 DOI: 10.1016/S0016-5085(98)82609-7 |
0.443 |
|
| 1999 |
Gaudin P, Rouyer-Fessard C, Couvineau A, Maoret JJ, Laburthe M. Constitutive activation of the human VIP1 receptor. Annals of the New York Academy of Sciences. 865: 382-5. PMID 9928034 DOI: 10.1111/J.1749-6632.1998.Tb11200.X |
0.444 |
|
| 1999 |
Nicole P, Du K, Couvineau A, Laburthe M. Site-directed mutagenesis of human VIP1 versus VIP2 receptors. Annals of the New York Academy of Sciences. 865: 378-81. PMID 9928033 DOI: 10.1111/J.1749-6632.1998.Tb11199.X |
0.415 |
|
| 1999 |
Couvineau A, Maoret JJ, Rouyer-Fessard C, Carrero I, Laburthe M. Cloning and functional characterization of the human VIP1/PACAP receptor promoter. Annals of the New York Academy of Sciences. 865: 59-63. PMID 9927997 DOI: 10.1111/J.1749-6632.1998.Tb11163.X |
0.345 |
|
| 1999 |
Gaudin P, Couvineau A, Rouyer-Fessard C, Maoret JJ, Laburthe M. The human vasoactive intestinal Peptide/Pituitary adenylate cyclase activating peptide receptor 1 (VPAC1): constitutive activation by mutations at threonine 343. Biochemical and Biophysical Research Communications. 254: 15-20. PMID 9920725 DOI: 10.1006/Bbrc.1998.9883 |
0.482 |
|
| 1999 |
Goumain M, Voisin T, Lorinet AM, Balasubramaniam A, Laburthe M. Pharmacological profile of the rat intestinal crypt peptide YY receptor vs. the recombinant rat Y5 receptor. European Journal of Pharmacology. 362: 245-9. PMID 9874177 DOI: 10.1016/S0014-2999(98)00757-2 |
0.552 |
|
| 1998 |
Goumain M, Voisin T, Lorinet AM, Laburthe M. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon. Biochemical and Biophysical Research Communications. 247: 52-6. PMID 9636652 DOI: 10.1006/Bbrc.1998.8647 |
0.478 |
|
| 1998 |
Rovère C, Barbero P, Maoret JJ, Laburthe M, Kitabgi P. Pro-neurotensin/neuromedin N expression and processing in human colon cancer cell lines. Biochemical and Biophysical Research Communications. 246: 155-9. PMID 9600085 DOI: 10.1006/Bbrc.1998.8506 |
0.346 |
|
| 1998 |
Gaudin P, Maoret JJ, Couvineau A, Rouyer-Fessard C, Laburthe M. Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors. The Journal of Biological Chemistry. 273: 4990-6. PMID 9478946 DOI: 10.1074/Jbc.273.9.4990 |
0.476 |
|
| 1998 |
DU K, NICOLE P, COUVINEAU A, LABURTHE M. Construction of Chimeras between Human VIP1 and Secretin Receptors: Identification of Receptor Domains Involved in Selectivity towards VIP, Secretin, and PACAP Annals of the New York Academy of Sciences. 865: 386-389. DOI: 10.1111/J.1749-6632.1998.Tb11201.X |
0.424 |
|
| 1998 |
Gaudin P, Maoret J, Couvineau A, Rouyer-Fessard C, Laburthe M. Constitutive activation of the human VIP1/PACAP receptor, a member of the new class II family of G protein-coupled receptors Gastroenterology. 114: A1144. DOI: 10.1016/S0016-5085(98)84652-0 |
0.381 |
|
| 1997 |
Souli A, Chariot J, Voisin T, Presset O, Tsocas A, Balasubramaniam A, Laburthe M, Rozé C. Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo. Peptides. 18: 551-7. PMID 9210175 DOI: 10.1016/S0196-9781(97)00069-7 |
0.54 |
|
| 1997 |
Du K, Nicole P, Couvineau A, Laburthe M. Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production. Biochemical and Biophysical Research Communications. 230: 289-92. PMID 9016768 DOI: 10.1006/Bbrc.1996.5949 |
0.443 |
|
| 1997 |
Gaudin P, Couvineau A, Maoret JJ, Rouyer-Fessard C, Laburthe M. Role of cysteine residues in the N-terminal extracellular domain of the human VIP 1 receptor for ligand binding. A site-directed mutagenesis study. Annals of the New York Academy of Sciences. 805: 585-9. PMID 8993444 DOI: 10.1111/J.1749-6632.1996.Tb17524.X |
0.381 |
|
| 1997 |
Gaudin P, Couvineau A, Maoret JJ, Rouyer-Fessard C, Laburthe M. Establishment of a CHO cell clone stably expressing the recombinant human VIP-1 receptor. Annals of the New York Academy of Sciences. 805: 570-3. PMID 8993441 DOI: 10.1111/J.1749-6632.1996.Tb17521.X |
0.431 |
|
| 1997 |
Couvineau A, Fabre C, Gaudin P, Maoret JJ, Laburthe M. Mutagenesis of N-glycosylation sites in the human VIP 1 receptor. Annals of the New York Academy of Sciences. 805: 558-62. PMID 8993439 DOI: 10.1111/J.1749-6632.1996.Tb17519.X |
0.389 |
|
| 1997 |
Laburthe M, Couvineau A, Gaudin P, Maoret JJ, Rouyer-Fessard C, Nicole P. Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors: structure-function relationship with special reference to the human VIP-1 receptor. Annals of the New York Academy of Sciences. 805: 94-109; discussion 1. PMID 8993396 DOI: 10.1111/J.1749-6632.1996.Tb17476.X |
0.411 |
|
| 1997 |
Gaudin P, Couvineau A, Maoret JJ, Rouyer-Fessard C, Laburthe M. Stable expression of the recombinant human VIP1 receptor in clonal Chinese hamster ovary cells: pharmacological, functional and molecular properties. European Journal of Pharmacology. 302: 207-14. PMID 8791009 DOI: 10.1016/0014-2999(96)00096-9 |
0.545 |
|
| 1996 |
Voisin T, Lorinet AM, Laburthe M. Partial knockdown of G alpha i2 protein is sufficient to abolish the coupling of PYY receptors to biological response in renal proximal tubule cells. Biochemical and Biophysical Research Communications. 225: 16-21. PMID 8769088 DOI: 10.1006/Bbrc.1996.1124 |
0.428 |
|
| 1996 |
Couvineau A, Rouyer-Fessard C, Maoret JJ, Gaudin P, Nicole P, Laburthe M. Vasoactive intestinal peptide (VIP)1 receptor. Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamide. The Journal of Biological Chemistry. 271: 12795-800. PMID 8662697 DOI: 10.1074/Jbc.271.22.12795 |
0.491 |
|
| 1996 |
Couvineau A, Fabre C, Gaudin P, Maoret JJ, Laburthe M. Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane. Biochemistry. 35: 1745-52. PMID 8639654 DOI: 10.1021/Bi952022H |
0.458 |
|
| 1996 |
Voisin T, Lorinet AM, Maoret JJ, Couvineau A, Laburthe M. G alpha i RNA antisense expression demonstrates the exclusive coupling of peptide YY receptors to G(i)2 proteins in renal proximal tubule cells. The Journal of Biological Chemistry. 271: 574-80. PMID 8550622 DOI: 10.1074/Jbc.271.1.574 |
0.38 |
|
| 1995 |
Couvineau A, Gaudin P, Maoret JJ, Rouyer-Fessard C, Nicole P, Laburthe M. Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP. Biochemical and Biophysical Research Communications. 206: 246-52. PMID 7818527 DOI: 10.1006/Bbrc.1995.1034 |
0.44 |
|
| 1995 |
Ogier-Denis E, Couvineau A, Maoret JJ, Houri JJ, Bauvy C, De Stefanis D, Isidoro C, Laburthe M, Codogno P. A heterotrimeric Gi3-protein controls autophagic sequestration in the human colon cancer cell line HT-29. The Journal of Biological Chemistry. 270: 13-6. PMID 7814364 DOI: 10.1074/Jbc.270.1.13 |
0.335 |
|
| 1995 |
Gaudin P, Couvineau A, Maoret JJ, Rouyer-Fessard C, Laburthe M. Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding. Biochemical and Biophysical Research Communications. 211: 901-8. PMID 7598720 DOI: 10.1006/Bbrc.1995.1897 |
0.436 |
|
| 1995 |
Lorinet AM, Javoy-Agid F, Laburthe M, Amiranoff B. Galanin receptors in human hypothalamus: biochemical and structural analysis. European Journal of Pharmacology. 269: 59-64. PMID 7530206 DOI: 10.1016/0922-4106(94)90026-4 |
0.461 |
|
| 1994 |
Balasubramaniam A, Cox HM, Voisin T, Laburthe M, Stein M, Fischer JE. Structure-activity studies of peptide YY(22-36): N-alpha-Ac-[Phe27]PYY(22-36), a potent antisecretory peptide in rat jejunum. Peptides. 14: 1011-6. PMID 8284251 DOI: 10.1016/0196-9781(93)90079-V |
0.424 |
|
| 1994 |
Couvineau A, Rouyer-Fessard C, Darmoul D, Maoret JJ, Carrero I, Ogier-Denis E, Laburthe M. Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochemical and Biophysical Research Communications. 200: 769-76. PMID 8179610 DOI: 10.1006/Bbrc.1994.1517 |
0.491 |
|
| 1994 |
Rodriguez-Henche N, Guijarro LG, Couvineau A, Carrero I, Arilla E, Laburthe M, Prieto JC. G proteins in rat liver proliferation during cholestasis. Hepatology (Baltimore, Md.). 20: 1041-7. PMID 7927206 DOI: 10.1002/Hep.1840200437 |
0.357 |
|
| 1994 |
Castan I, Valet P, Quideau N, Voisin T, Ambid L, Laburthe M, Lafontan M, Carpéné C. Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes. The American Journal of Physiology. 266: R1141-7. PMID 7910434 DOI: 10.1152/Ajpregu.1994.266.4.R1141 |
0.406 |
|
| 1994 |
Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, Mayaux JF. Molecular cloning of a functional human galanin receptor. Proceedings of the National Academy of Sciences of the United States of America. 91: 9780-3. PMID 7524088 DOI: 10.1073/Pnas.91.21.9780 |
0.494 |
|
| 1994 |
Maoret JJ, Pospaï D, Rouyer-Fessard C, Couvineau A, Laboisse C, Voisin T, Laburthe M. Neurotensin receptor and its mRNA are expressed in many human colon cancer cell lines but not in normal colonic epithelium: binding studies and RT-PCR experiments. Biochemical and Biophysical Research Communications. 203: 465-71. PMID 7521165 DOI: 10.1006/Bbrc.1994.2205 |
0.407 |
|
| 1994 |
Laburthe M, Couvineau A, Amiranoff B, Voisin T. Receptors for gut regulatory peptides. Bailliere's Clinical Endocrinology and Metabolism. 8: 77-110. PMID 7510949 DOI: 10.1016/S0950-351X(05)80227-7 |
0.516 |
|
| 1993 |
Castan I, Valet P, Larrouy D, Voisin T, Remaury A, Daviaud D, Laburthe M, Lafontan M. Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the alpha 2-adrenergic system. The American Journal of Physiology. 265: E74-80. PMID 8393293 DOI: 10.1152/Ajpendo.1993.265.1.E74 |
0.466 |
|
| 1993 |
Fabre C, Battari AE, Karamanos Y, Couvineau A, Salomon R, Laburthe M, Marvaldi J, Pichon J, Luis J. Glycosylation of VIP receptors: A molecular basis for receptor heterogeneity Peptides. 14: 483-489. PMID 8392717 DOI: 10.1016/0196-9781(93)90136-5 |
0.418 |
|
| 1993 |
Fournier A, Couvineau A, Laburthe M. Synthesis of a hydrophilic affinity matrix for the purification of the vasoactive intestinal peptide receptor. Analytical Biochemistry. 211: 305-10. PMID 8391225 DOI: 10.1006/Abio.1993.1274 |
0.401 |
|
| 1993 |
Salomon R, Couvineau A, Rouyer-Fessard C, Voisin T, Lavallée D, Blais A, Darmoul D, Laburthe M. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium. The American Journal of Physiology. 264: E294-300. PMID 8383439 DOI: 10.1152/Ajpendo.1993.264.2.E294 |
0.545 |
|
| 1993 |
Chen Y, Fournier A, Couvineau A, Laburthe M, Amiranoff B. Purification of a galanin receptor from pig brain. Proceedings of the National Academy of Sciences of the United States of America. 90: 3845-9. PMID 7683410 DOI: 10.1073/Pnas.90.9.3845 |
0.425 |
|
| 1993 |
Amiranoff B, Chen Y, Fournier A, Couvineau A, Laburthe M. The brain galanin receptor: Purification by a one-step affinity chromatography Neuropeptides. 24: 243. DOI: 10.1016/0143-4179(93)90267-E |
0.356 |
|
| 1992 |
Laburthe M. [Peptide YY and neuropeptide Y in the intestine: availability, biologic effects and epithelial receptors]. Archives Internationales De Physiologie, De Biochimie Et De Biophysique. 99: A177. PMID 1720689 DOI: 10.3109/13813459109145924 |
0.384 |
|
| 1992 |
Chen Y, Laburthe M, Amiranoff B. Galanin inhibits adenylate cyclase of rat brain membranes. Peptides. 13: 339-41. PMID 1384008 DOI: 10.1016/0196-9781(92)90118-M |
0.438 |
|
| 1992 |
Couvineau A, Darmoul D, Blais A, Rouyer-Fessard C, Daviaud D, Voisin T, Paris H, Rouot B, Laburthe M. Gs and Gi protein subunits during cell differentiation in intestinal crypt-villus axis: regulation at the mRNA level. The American Journal of Physiology. 262: C1478-84. PMID 1377446 DOI: 10.1152/Ajpcell.1992.262.6.C1478 |
0.37 |
|
| 1992 |
Chen Y, Couvineau A, Laburthe M, Amiranoff B. Solubilization and molecular characterization of active galanin receptors from rat brain. Biochemistry. 31: 2415-22. PMID 1371697 DOI: 10.1021/Bi00123A029 |
0.382 |
|
| 1992 |
Castan I, Valet P, Voisin T, Quideau N, Laburthe M, Lafontan M. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes. Endocrinology. 131: 1970-6. PMID 1327725 DOI: 10.1210/Endo.131.4.1327725 |
0.498 |
|
| 1992 |
Guijarro LG, Couvineau A, Rodriguez-Pena MS, Juarranz MG, Rodriguez-Henche N, Arilla E, Laburthe M, Prieto JC. Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy. Biochemical Journal. 285: 515-520. PMID 1322136 DOI: 10.1042/Bj2850515 |
0.463 |
|
| 1992 |
Augeron C, Voisin T, Maoret JJ, Berthon B, Laburthe M, Laboisse CL. Neurotensin and neuromedin N stimulate mucin output from human goblet cells (Cl.16E) via neurotensin receptors. The American Journal of Physiology. 262: G470-6. PMID 1312794 DOI: 10.1152/Ajpgi.1992.262.3.G470 |
0.442 |
|
| 1992 |
Salomon R, Couvineau A, Rouyer-Fessard C, Voisin T, Lavallée D, Blais A, Darmoul D, Laburthe M. Common VIP / PACAP receptor in human small intestinal epithelium Regulatory Peptides. 40: 242. DOI: 10.1016/0167-0115(92)90402-G |
0.461 |
|
| 1991 |
Grey V, Rouyer-Fessard C, Gammeltoft S, Bourque M, Morin C, Laburthe M. Insulin-like growth factor II/mannose-6-phosphate receptors are transiently increased in the rat distal intestinal epithelium after resection. Molecular and Cellular Endocrinology. 75: 221-7. PMID 1851113 DOI: 10.1016/0303-7207(91)90164-N |
0.372 |
|
| 1991 |
Amiranoff B, Lorinet AM, Laburthe M. A clonal rat pancreatic delta cell line (Rin14B) expresses a high number of galanin receptors negatively coupled to a pertussis-toxin-sensitive cAMP-production pathway. European Journal of Biochemistry. 195: 459-63. PMID 1847683 DOI: 10.1111/J.1432-1033.1991.Tb15726.X |
0.516 |
|
| 1991 |
Voisin T, Couvineau A, Guijarro L, Laburthe M. VIP receptors from porcine liver: high yield solubilization in a GTP-insensitive form. Life Sciences. 48: 135-41. PMID 1847224 DOI: 10.1016/0024-3205(91)90406-2 |
0.508 |
|
| 1991 |
Amiranoff B, Lorinet AM, Laburthe M. Galanin inhibits somatostatin release by the rat islet cell tumor in culture, Rin-m. European Journal of Pharmacology. 191: 401-5. PMID 1707817 DOI: 10.1016/0014-2999(90)94174-V |
0.404 |
|
| 1991 |
Darmoul D, Rouyer-Fessard C, Blais A, Voisin T, Sapin C, Baricault L, Cibert C, Geraud G, Couvineau A, Laburthe M. Dipeptidyl peptidase IV expression in rat jejunal crypt-villus axis is controlled at mRNA level. The American Journal of Physiology. 261: G763-9. PMID 1683165 DOI: 10.1152/Ajpgi.1991.261.5.G763 |
0.354 |
|
| 1990 |
Rouyer-Fessard C, Augeron C, Grasset E, Maoret JJ, Laboisse CL, Laburthe M. VIP receptors and control of short circuit current in the human intestinal clonal cell line Cl.19A. Experientia. 45: 1102-5. PMID 2557231 DOI: 10.1007/Bf01950169 |
0.454 |
|
| 1990 |
Voisin T, Rouyer-Fessard C, Laburthe M. Distribution of common peptide YY-neuropeptide Y receptor along rat intestinal villus-crypt axis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 258. PMID 2159240 DOI: 10.1152/Ajpgi.1990.258.5.G753 |
0.558 |
|
| 1990 |
Couvineau A, Rouyer-Fessard C, Voisin T, Laburthe M. Functional and immunological evidence for stable association of solubilized vasoactive-intestinal-peptide receptor and stimulatory guanine-nucleotide-binding protein from rat liver. European Journal of Biochemistry. 187: 605-9. PMID 2154377 DOI: 10.1111/J.1432-1033.1990.Tb15343.X |
0.411 |
|
| 1990 |
Rouyer-Fessard C, Gammeltoft S, Laburthe M. Expression of two types of receptor for insulinlike growth factors in human colonic epithelium. Gastroenterology. 98: 703-707. PMID 2153600 DOI: 10.1016/0016-5085(90)90291-8 |
0.339 |
|
| 1990 |
VOISIN T, ROUYER-FESSARD C, LABURTHE M. Peptide YY/Neuropeptide Y Receptors in Small Intestine. Annals of the New York Academy of Sciences. 611: 343-346. DOI: 10.1111/J.1749-6632.1990.Tb48945.X |
0.477 |
|
| 1989 |
Lorinet AM, Tatemoto K, Laburthe M, Amiranoff B. Pancreastatin inhibits insulin release from Rin m 5F cells: reversion by pertussis toxin. European Journal of Pharmacology. 160: 405-7. PMID 2653848 DOI: 10.1016/0014-2999(89)90097-6 |
0.362 |
|
| 1989 |
Rouyer-Fessard C, Couvineau A, Voisin T, Laburthe M. Ac-Tyr1hGRF discriminates between VIP receptors from rat liver and intestinal epithelium. Life Sciences. 45: 829-33. PMID 2549322 DOI: 10.1016/0024-3205(89)90176-8 |
0.494 |
|
| 1989 |
Calvo JR, Couvineau A, Guijarro L, Laburthe M. Solubilization and hydrodynamic characterization of guanine nucleotide sensitive vasoactive intestinal peptide-receptor complexes from rat intestine. Biochemistry. 28: 1667-72. PMID 2541761 DOI: 10.1021/Bi00430A036 |
0.446 |
|
| 1989 |
Guijarro L, Couvineau A, Calvo JR, Laburthe M. Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver. Regulatory Peptides. 25: 37-50. PMID 2541470 DOI: 10.1016/0167-0115(89)90246-2 |
0.512 |
|
| 1989 |
Laburthe M, Augeron C, Rouyer-Fessard C, Roumagnac I, Maoret JJ, Grasset E, Laboisse C. Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E. The American Journal of Physiology. 256: G443-50. PMID 2538074 DOI: 10.1152/Ajpgi.1989.256.3.G443 |
0.467 |
|
| 1989 |
Servin AL, Rouyer-Fessard C, Balasubramaniam A, Saint Pierre S, Laburthe M. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors. Endocrinology. 124: 692-700. PMID 2536315 DOI: 10.1210/Endo-124-2-692 |
0.534 |
|
| 1989 |
Lagny-Pourmir I, Lorinet AM, Yanaihara N, Laburthe M. Structural requirements for galanin interaction with receptors from pancreatic beta cells and from brain tissue of the rat. Peptides. 10: 757-761. PMID 2479930 DOI: 10.1016/0196-9781(89)90109-5 |
0.455 |
|
| 1989 |
Amiranoff B, Lorinet AM, Yanaihara N, Laburthe M. Structural requirement for galanin action in the pancreatic beta cell line Rin m 5F. European Journal of Pharmacology. 163: 205-7. PMID 2472967 DOI: 10.1016/0014-2999(89)90421-4 |
0.35 |
|
| 1989 |
Lagny-Pourmir I, Amiranoff B, Lorinet AM, Tatemoto K, Laburthe M. Characterization of galanin receptors in the insulin-secreting cell line Rin m 5F: evidence for coupling with a pertussis toxin-sensitive guanosine triphosphate regulatory protein. Endocrinology. 124: 2635-41. PMID 2468476 DOI: 10.1210/Endo-124-5-2635 |
0.484 |
|
| 1989 |
Voisin T, Rouyer-Fessard C, Couvineau A, Laburthe M. Interplay between VIP and PYY/NPY receptors during enterocytic differentiation along the crypt-villus axis in rat small intestine Regulatory Peptides. 26: 183. DOI: 10.1016/0167-0115(89)90087-6 |
0.439 |
|
| 1989 |
Couvineau A, Voisin T, Guijarro L, Laburthe M. Abstract of the Fourth International Symposium on VIP and Related Peptides Stockholm, 21–23 September 1989Solubilization of active VIP-receptor from porcine liver in a GTP-insensitive, G protein-free form Regulatory Peptides. 26: 149. DOI: 10.1016/0167-0115(89)90026-8 |
0.42 |
|
| 1989 |
Couvineau A, Rouyer-Fessard C, Voisin T, Laburthe M. Stable association of solubilized VIP receptor and Gs protein in rat liver: Immunological and functional evidences Regulatory Peptides. 26: 149. DOI: 10.1016/0167-0115(89)90025-6 |
0.367 |
|
| 1988 |
Laburthe M, Rouyer-Fessard C, Gammeltoft S. Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. The American Journal of Physiology. 254: G457-62. PMID 2964791 DOI: 10.1152/Ajpgi.1988.254.3.G457 |
0.399 |
|
| 1988 |
Laburthe M, Couvineau A. Molecular analysis of vasoactive intestinal peptide receptors. A comparison with receptors for VIP-related peptides. Annals of the New York Academy of Sciences. 527: 296-313. PMID 2839083 DOI: 10.1111/J.1749-6632.1988.Tb26988.X |
0.471 |
|
| 1988 |
Amiranoff B, Lorinet AM, Lagny-Pourmir I, Laburthe M. Mechanism of galanin-inhibited insulin release. Occurrence of a pertussis-toxin-sensitive inhibition of adenylate cyclase. European Journal of Biochemistry. 177: 147-52. PMID 2460348 DOI: 10.1111/J.1432-1033.1988.Tb14355.X |
0.373 |
|
| 1987 |
Amiranoff B, Servin AL, Rouyer-Fessard C, Couvineau A, Tatemoto K, Laburthe M. Galanin receptors in a hamster pancreatic beta-cell tumor: identification and molecular characterization. Endocrinology. 121: 284-9. PMID 2439312 DOI: 10.1210/Endo-121-1-284 |
0.468 |
|
| 1987 |
Servin AL, Amiranoff B, Rouyer-Fessard C, Tatemoto K, Laburthe M. Identification and molecular characterization of galanin receptor sites in rat brain. Biochemical and Biophysical Research Communications. 144: 298-306. PMID 2437911 DOI: 10.1016/S0006-291X(87)80510-7 |
0.457 |
|
| 1986 |
Amiranoff B, Couvineau A, Vauclin-Jacques N, Laburthe M. Gastric inhibitory polypeptide receptor in hamster pancreatic beta cells. Direct cross-linking, solubilization and characterization as a glycoprotein. European Journal of Biochemistry. 159: 353-8. PMID 3530757 DOI: 10.1111/J.1432-1033.1986.Tb09875.X |
0.453 |
|
| 1986 |
Couvineau A, Gammeltoft S, Laburthe M. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex. Journal of Neurochemistry. 47: 1469-75. PMID 3020175 DOI: 10.1111/J.1471-4159.1986.Tb00780.X |
0.491 |
|
| 1986 |
Laburthe M, Chenut B, Rouyer-Fessard C, Tatemoto K, Couvineau A, Servin A, Amiranoff B. Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide. Endocrinology. 118: 1910-7. PMID 3009142 DOI: 10.1210/Endo-118-5-1910 |
0.445 |
|
| 1986 |
Laburthe M. [Vasoactive intestinal peptide (VIP): a ubiquitous neuropeptide member of structural family of regulatory peptides]. Biochimie. 67: XI-XVII. PMID 3006796 DOI: 10.1016/S0300-9084(85)80122-X |
0.358 |
|
| 1985 |
Couvineau A, Laburthe M. The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor. The Biochemical Journal. 225: 473-9. PMID 3977841 DOI: 10.1042/bj2250473 |
0.31 |
|
| 1985 |
Couvineau A, Rousset M, Laburthe M. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29. The Biochemical Journal. 231: 139-43. PMID 2998337 DOI: 10.1042/Bj2310139 |
0.455 |
|
| 1985 |
Couvineau A, Laburthe M. The human vasoactive intestinal peptide receptor: molecular identification by covalent cross-linking in colonic epithelium. The Journal of Clinical Endocrinology and Metabolism. 61: 50-5. PMID 2987295 DOI: 10.1210/Jcem-61-1-50 |
0.452 |
|
| 1985 |
Sarrieau A, Boige N, Laburthe M. Role of phospholipids in the binding activity of vasoactive intestinal peptide receptors. Experientia. 41: 631-3. PMID 2987022 DOI: 10.1007/Bf02007693 |
0.481 |
|
| 1985 |
Rousset M, Laburthe M, Pinto M, Chevalier G, Rouyer-Fessard C, Dussaulx E, Trugnan G, Boige N, Brun JL, Zweibaum A. Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin. Journal of Cellular Physiology. 123: 377-85. PMID 2985631 DOI: 10.1002/Jcp.1041230313 |
0.765 |
|
| 1985 |
Amiranoff B, Vauclin-Jacques N, Laburthe M. Interaction of gastric inhibitory polypeptide (GIP) with the insulin-secreting pancreatic beta cell line, In lll: characteristics of GIP binding sites. Life Sciences. 36: 807-13. PMID 2983172 DOI: 10.1016/0024-3205(85)90203-6 |
0.381 |
|
| 1985 |
Laburthe M, Couvineau A, Rouyer-Fessard C, Moroder L. Interaction of PHM, PHI and 24-glutamine PHI with human VIP receptors from colonic epithelium: comparison with rat intestinal receptors. Life Sciences. 36: 991-5. PMID 2983161 DOI: 10.1016/0024-3205(85)90396-0 |
0.571 |
|
| 1985 |
Couvineau A, Gammeltoft S, Laburthe M. Molecular identification and structural requirement of VIP receptors in rat brain synaptosomes Regulatory Peptides. 10: S33. DOI: 10.1016/0167-0115(85)90342-8 |
0.359 |
|
| 1985 |
Couvineau A, Laburthe M. Covalent cross-linking of VIP to its human receptor in colonic epithelium Regulatory Peptides. 10: S32. DOI: 10.1016/0167-0115(85)90341-6 |
0.418 |
|
| 1985 |
Laburthe M, Couvineau A, Rouyer-Fessard C. Species specificity in GRF interaction with VIP receptors: Discovery of a competitive VIP antagonist Regulatory Peptides. 10. DOI: 10.1016/0167-0115(85)90340-4 |
0.382 |
|
| 1985 |
Laburthe M, Couvineau A, Rousset M, Rouyer-Fessard C. Cellular expression and molecular identification of peripheral VIP receptors Regulatory Peptides. 10. DOI: 10.1016/0167-0115(85)90286-1 |
0.365 |
|
| 1984 |
Boige N, Amiranoff B, Munck A, Laburthe M. Forskolin stimulates adenylate cyclase in human colonic crypts: interaction with VIP. European Journal of Pharmacology. 101: 111-7. PMID 6540196 DOI: 10.1016/0014-2999(84)90036-0 |
0.777 |
|
| 1984 |
Maletti M, Portha B, Carlquist M, Kergoat M, Laburthe M, Marie JC, Rosselin G. Evidence for and characterization of specific high affinity binding sites for the gastric inhibitory polypeptide in pancreatic beta-cells. Endocrinology. 115: 1324-31. PMID 6383787 DOI: 10.1210/Endo-115-4-1324 |
0.406 |
|
| 1984 |
Couvineau A, Amiranoff B, Vauclin-Jacques N, Laburthe M. The GIP receptor on pancreatic beta cell tumor: molecular identification by covalent cross-linking. Biochemical and Biophysical Research Communications. 122: 283-8. PMID 6331448 DOI: 10.1016/0006-291X(84)90472-8 |
0.396 |
|
| 1984 |
Couvineau A, Rouyer-Fessard C, Fournier A, St Pierre S, Pipkorn R, Laburthe M. Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences. Biochemical and Biophysical Research Communications. 121: 493-8. PMID 6329205 DOI: 10.1016/0006-291X(84)90209-2 |
0.489 |
|
| 1984 |
Laburthe M, Breant B, Rouyer-Fessard C. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross-linking. Evidence for two classes of binding sites with different structural and functional properties. European Journal of Biochemistry. 139: 181-7. PMID 6321173 DOI: 10.1111/J.1432-1033.1984.Tb07992.X |
0.488 |
|
| 1984 |
Amiranoff B, Vauclin-Jacques N, Boige N, Rouyer-Fessard C, Laburthe M. Interaction of Gila monster venom with VIP receptors in intestinal epithelium of human. A comparison with rat. Febs Letters. 164: 299-302. PMID 6317454 DOI: 10.1016/0014-5793(83)80305-6 |
0.817 |
|
| 1984 |
Boige N, Munck A, Laburthe M. Adrenergic versus VIPergic control of cyclic AMP in human colonic crypts. Peptides. 5: 379-83. PMID 6147817 DOI: 10.1016/0196-9781(84)90238-9 |
0.785 |
|
| 1984 |
Amiranoff B, Vauclin-Jacques N, Laburthe M. Functional GIP receptors in a hamster pancreatic beta cell line, In 111: specific binding and biological effects. Biochemical and Biophysical Research Communications. 123: 671-6. PMID 6091638 DOI: 10.1016/0006-291X(84)90281-X |
0.449 |
|
| 1984 |
Roomi N, Laburthe M, Fleming N, Crowther R, Forstner J. Cholera-induced mucin secretion from rat intestine: lack of effect of cAMP, cycloheximide, VIP, and colchicine. The American Journal of Physiology. 247: G140-8. PMID 6087674 DOI: 10.1152/ajpgi.1984.247.2.G140 |
0.303 |
|
| 1983 |
Sarrieau A, Laburthe M, Rosselin G. Intestinal VIP receptors: differential effect of trypsin on the high and low affinity binding sites. Molecular and Cellular Endocrinology. 31: 301-13. PMID 6313449 DOI: 10.1016/0303-7207(83)90156-9 |
0.36 |
|
| 1983 |
Laburthe M, Amiranoff B, Boige N, Rouyer-Fessard C, Tatemoto K, Moroder L. Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin. Febs Letters. 159: 89-92. PMID 6307754 DOI: 10.1016/0014-5793(83)80422-0 |
0.81 |
|
| 1983 |
Laburthe M, Breant B, Rouyer-Fessard C. VIP receptors: covalent labeling and molecular identification ☆ Regulatory Peptides. 6: 314. DOI: 10.1016/0167-0115(83)90207-0 |
0.367 |
|
| 1983 |
Laburthe M, Amiranoff B, Boige N, Rouyer-Fessard C, Tatemoto K, Moroder L. GRF interaction with VIP receptors in human and rat intestinal epithelial membranes: Comparison with PHI and secretin Regulatory Peptides. 6: 314. DOI: 10.1016/0167-0115(83)90206-9 |
0.789 |
|
| 1983 |
Boige N, Munck A, Laburthe M. Abstract of the First International Symposium on Vasoactive Intestinal Peptide (VIP) and related peptides Brussels, Belgium, September 14–16, 1983VIPergic versus adrenergic control of cyclic AMP in human colonic crypts Regulatory Peptides. 6: 292. DOI: 10.1016/0167-0115(83)90164-7 |
0.775 |
|
| 1982 |
Laburthe M, Amiranoff B, Boissard C. Alpha-Adrenergic inhibition of cyclic AMP accumulation in epithelial cells isolated from rat small intestine. Biochimica Et Biophysica Acta. 721: 101-8. PMID 6127115 DOI: 10.1016/0167-4889(82)90029-5 |
0.437 |
|
| 1982 |
Forgue-Lafitte ME, Laburthe M, Rosselin G, Zweibaum A. Receptors for Regulatory Peptides in Epithelial Gut Cancer Protides of the Biological Fluids. 29: 595-598. DOI: 10.1016/B978-0-08-027988-6.50140-3 |
0.482 |
|
| 1982 |
Laburthe M, Amiranoff B, Dupont C, Gespach C, Rosselin G. Vasoactive Intestinal Peptide (VIP) Control of Cyclic amp Accumulation in Digestive Epithelia: Involvement of Multiple Regulatory Processes Protides of the Biological Fluids. 29: 513-516. DOI: 10.1016/B978-0-08-027988-6.50120-8 |
0.481 |
|
| 1981 |
Rousset M, Laburthe M, Chevalier G, Boissard C, Rosselin G, Zweibaum A. Vasoactive intestinal peptide (VIP) control of glycogenolysis in the human colon carcinoma cell line HT-29 in culture. Febs Letters. 126: 38-40. PMID 6263686 DOI: 10.1016/0014-5793(81)81027-7 |
0.372 |
|
| 1981 |
Dupont C, Broyart JP, Broer Y, Chenut B, Laburthe M, Rosselin G. Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3',5'-monophosphate in gallbladder epithelial cells of man. Comparison with the guinea pig. The Journal of Clinical Investigation. 67: 742-52. PMID 6259209 DOI: 10.1172/Jci110091 |
0.489 |
|
| 1981 |
Broyart JP, Dupont C, Laburthe M, Rosselin G. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells. The Journal of Clinical Endocrinology and Metabolism. 52: 715-21. PMID 6259191 DOI: 10.1210/Jcem-52-4-715 |
0.462 |
|
| 1981 |
Prieto JC, Laburthe M, Hoa DH, Rosselin G. Quantitative studies of vasoactive intestinal peptide (VIP) binding sites and VIP-induced adenosine 3':5'-monophosphate production in epithelial cells from duodenum, jejunum, ileum, cecum, colon and rectum in the rat. Acta Endocrinologica. 96: 100-6. PMID 6257013 DOI: 10.1530/Acta.0.0960100 |
0.463 |
|
| 1981 |
Amiranoff B, Laburthe M, Rosselin G. Differential effects of guanine nucleotides on the first step of VIP and glucagon action in membranes from liver cells. Biochemical and Biophysical Research Communications. 96: 463-8. PMID 6254514 DOI: 10.1016/0006-291X(80)91237-1 |
0.448 |
|
| 1981 |
Laburthe M, Boissard C, Chevalier G, Zweibaum A, Rosselin G. Peptide receptors in human lung tumor cells in culture: vasoactive intestinal peptide (VIP) and secretin interaction with the Calu-1 and SW-900 cell lines. Regulatory Peptides. 2: 219-30. PMID 6169119 DOI: 10.1016/0167-0115(81)90026-4 |
0.402 |
|
| 1981 |
Dupont C, Gespach C, Laburthe M, Rosselin G, Canlorbe P. Prevalence of vasoactive intestinal peptide (VIP) in the regulation of cyclic AMP production in digestive epithelia: a specific feature of human Pediatric Research. 15: 82-82. DOI: 10.1203/00006450-198101000-00064 |
0.551 |
|
| 1980 |
Amiranoff B, Laburthe M, Rosselin G. Potentiation by guanine nucleotides of the VIP-induced adenylate cyclase stimulation in intestinal epithelial cell membranes. Life Sciences. 26: 1905-11. PMID 7401908 DOI: 10.1016/0024-3205(80)90620-7 |
0.422 |
|
| 1980 |
Maletti M, Besson J, Bataille D, Laburthe M, Rosselin G. Ontogeny and immunoreactive forms of vasoactive intestinal peptide (VIP) in rat brain. Acta Endocrinologica. 93: 479-87. PMID 7386117 DOI: 10.1530/Acta.0.0930479 |
0.382 |
|
| 1980 |
Amiranoff B, Laburthe M, Rosselin G. Characterization of specific binding sites for vasoactive intestinal peptide in rat intestinal epithelial cell membranes. Biochimica Et Biophysica Acta. 627: 215-24. PMID 7350925 DOI: 10.1016/0304-4165(80)90323-2 |
0.461 |
|
| 1980 |
Forgue-Lafitte ME, Laburthe M, Chamblier MC, Moody AJ, Rosselin G. Demonstration of specific receptors for EGF--urogastrone in isolated rat intestinal epithelial cells. Febs Letters. 114: 243-6. PMID 6248368 DOI: 10.1016/0014-5793(80)81125-2 |
0.465 |
|
| 1980 |
Bataille D, Gespach C, Laburthe M, Amiranoff B, Tatemoto K, Vauclin N, Mutt V, Rosselin G. Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat. Febs Letters. 114: 240-2. PMID 6248367 DOI: 10.1016/0014-5793(80)81124-0 |
0.397 |
|
| 1980 |
Dupont C, Laburthe M, Broyart JP, Bataille D, Rosselin G. Cyclic AMP production in isolated colonic epithelial crypts: a highly sensitive model for the evaluation of vasoactive intestinal peptide action in human intestine. European Journal of Clinical Investigation. 10: 67-76. PMID 6245891 DOI: 10.1111/J.1365-2362.1980.Tb00012.X |
0.459 |
|
| 1980 |
Laburthe M, Mangeat P, Marchis-Mouren G, Rosselin G. Activation of cyclic AMP-dependent protein kinases by vasoactive intestinal peptide (VIP) in isolated intestinal epithelial cells from rat. Life Sciences. 25: 1931-7. PMID 231169 DOI: 10.1016/0024-3205(79)90615-5 |
0.41 |
|
| 1980 |
Bataille D, Gespach C, Laburthe M, Amiranoff B, Tatemoto K, Vauclin N, Mutt V, Rosselin G. VIP- and secretin-like effects of the porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) in the rat Regulatory Peptides. 1: S8. DOI: 10.1016/0167-0115(80)90035-X |
0.371 |
|
| 1979 |
Amiranoff B, Laburthe M, Dupont C, Rosselin G. Characterization of a vasoactive intestinal peptide-sensitive adenylate cyclase in rat intestinal epithelial cell membranes. Biochimica Et Biophysica Acta. 544: 474-81. PMID 728466 DOI: 10.1016/0304-4165(78)90321-5 |
0.485 |
|
| 1979 |
Besson J, Rotsztejn W, Laburthe M, Epelbaum J, Beaudet A, Kordon C, Rosselin G. Vasoactive intestinal peptide (VIP): brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in male rats. Brain Research. 165: 79-85. PMID 427588 DOI: 10.1016/0006-8993(79)90046-5 |
0.382 |
|
| 1979 |
Morera AM, Cathiard AM, Laburthe M, Saez JM. Interaction of vasoactive intestinal peptide (VIP) with a mouse adrenal cell line (Y-1): specific binding and biological effects. Biochemical and Biophysical Research Communications. 90: 78-85. PMID 227394 DOI: 10.1016/0006-291X(79)91592-4 |
0.454 |
|
| 1979 |
Laburthe M, Rosselin G, Rousset M, Zweibaum A, Korner M, Selinger Z, Schramm M. Transfer of the hormone receptor for vaso-intestinal peptide to an adenylate cyclase system in another cell. Febs Letters. 98: 41-3. PMID 218842 DOI: 10.1016/0014-5793(79)80147-7 |
0.48 |
|
| 1979 |
Laburthe M, Prieto JC, Amiranoff B, Dupont C, Hui Bon Hoa D, Rosselin G. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 2. Characterization and structural requirements of the stimulatory effect of vasoactive intestinal peptide on production of adenosine 3':5'-monophosphate. European Journal of Biochemistry. 96: 239-48. PMID 88368 DOI: 10.1111/j.1432-1033.1979.tb13034.x |
0.373 |
|
| 1979 |
Prieto JC, Laburthe M, Rosselin G. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 1. Characterization, quantitative aspects and structural requirements of binding sites. European Journal of Biochemistry. 96: 229-37. PMID 37084 DOI: 10.1111/J.1432-1033.1979.Tb13033.X |
0.457 |
|
| 1979 |
Dupont C, Laburthe M, Besson J, Rosselin G. Stimulation of cyclic AMP (cAMP) accumulation in epithelial cells of human colon by plasma from children with watery diarrhea syndrome (WDS): role of vasoactive intestinal peptide (VIP). Pediatric Research. 13: 1184-1184. DOI: 10.1203/00006450-197910000-00024 |
0.407 |
|
| 1978 |
Besson J, Laburthe M, Bataille D, Dupont C, Rosselin G. Vasoactive intestinal peptide (VIP): tissue distribution in the rat as measured by radioimmunoassay and by radioreceptorassay. Acta Endocrinologica. 87: 799-810. PMID 580524 DOI: 10.1530/Acta.0.0870799 |
0.37 |
|
| 1978 |
Laburthe M, Rousset M, Boissard C, Chevalier G, Zweibaum A, Rosselin G. Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proceedings of the National Academy of Sciences of the United States of America. 75: 2772-5. PMID 208077 DOI: 10.1073/Pnas.75.6.2772 |
0.469 |
|
| 1977 |
Laburthe M, Bataille D, Rosselin G. Vasoactive intestinal peptide (VIP): variation of the jejuno-ileal content in the developing rat as measured by radioreceptorassay. Acta Endocrinologica. 84: 588-99. PMID 576532 DOI: 10.1530/Acta.0.0840588 |
0.372 |
|
| Show low-probability matches. |